Regulation of skeletal muscle development and homeostasis by gene imprinting, histone acetylation and microRNA

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1849, Issue 3, 2015, Pages 309-316

  Moresi, Viviana ^a   Marroncelli, Nicoletta ^a   Coletti, Dario ^a   Adamo, Sergio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

DNA methylase; HDACi; HDACs; MyomiRs

Indexed keywords

HISTONE; HISTONE DEACETYLASE INHIBITOR; MICRORNA; HISTONES; MICRORNAS;

DNA METHYLATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENOME IMPRINTING; HISTONE ACETYLATION; HISTONE MODIFICATION; HOMEOSTASIS; HUMAN; MUSCLE DEVELOPMENT; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; ACETYLATION; EPIGENESIS, GENETIC; GENETICS; GENOMIC IMPRINTING; GROWTH AND DEVELOPMENT; HUMANS; METABOLISM; MUSCLE, SKELETAL; PROTEIN PROCESSING, POST-TRANSLATIONAL;

ACETYLATION; DNA METHYLATION; EPIGENESIS, GENETIC; GENOMIC IMPRINTING; HISTONES; HOMEOSTASIS; HUMANS; MICRORNAS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84921927758     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2015.01.002     Document Type: Review

References (120)

1. Waddington C.H. The epigenotype. 1942. Int. J. Epidemiol. 2012, 41:10-13.
2. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007, 447:425-432.
3. Segales J., Perdiguero E., Munoz-Canoves P. Epigenetic control of adult skeletal muscle stem cell functions. FEBS J. 2014, 10.1111/febs.13065.
4. Ambros V. microRNAs: tiny regulators with great potential. Cell 2001, 107:823-826.
5. Geeleher P., Huang S.R., Gamazon E.R., Golden A., Seoighe C. The regulatory effect of miRNAs is a heritable genetic trait in humans. BMC Genomics 2012, 13:383.
6. Yelin R., Dahary D., Sorek R., Levanon E.Y., Goldstein O., Shoshan A., Diber A., Biton S., Tamir Y., Khosravi R., Nemzer S., Pinner E., Walach S., Bernstein J., Savitsky K., Rotman G. Widespread occurrence of antisense transcription in the human genome. Nat. Biotechnol. 2003, 21:379-386.
7. Pinney S.E. Mammalian non-CpG methylation: stem cells and beyond. Biology (Basel) 2014, 3:739-751.
8. Bartolomei M.S., Ferguson-Smith A.C. Mammalian genomic imprinting. Cold Spring Harb. Perspect. Biol. 2011, 3.
9. Moore T., Haig D. Genomic imprinting in mammalian development: a parental tug-of-war. Trends Genet. 1991, 7:45-49.
10. Spencer H.G., Feldman M.W., Clark A.G. Genetic conflicts, multiple paternity and the evolution of genomic imprinting. Genetics 1998, 148:893-904.
11. Pannerec A., Marazzi G., Sassoon D. Stem cells in the hood: the skeletal muscle niche. Trends Mol. Med. 2012, 18:599-606.
12. Berg J.S., Lin K.K., Sonnet C., Boles N.C., Weksberg D.C., Nguyen H., Holt L.J., Rickwood D., Daly R.J., Goodell M.A. Imprinted genes that regulate early mammalian growth are coexpressed in somatic stem cells. PLoS One 2011, 6:e26410.
13. Lui J.C., Finkielstain G.P., Barnes K.M., Baron J. An imprinted gene network that controls mammalian somatic growth is down-regulated during postnatal growth deceleration in multiple organs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R189-R196.
14. Besson V., Smeriglio P., Wegener A., Relaix F., Nait O.B., Sassoon D.A., Marazzi G. PW1 gene/paternally expressed gene 3 (PW1/Peg3) identifies multiple adult stem and progenitor cell populations. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:11470-11475.
15. Relaix F., Weng X., Marazzi G., Yang E., Copeland N., Jenkins N., Spence S.E., Sassoon D. Pw1, a novel zinc finger gene implicated in the myogenic and neuronal lineages. Dev. Biol. 1996, 177:383-396.
16. Nicolas N., Marazzi G., Kelley K., Sassoon D. Embryonic deregulation of muscle stress signaling pathways leads to altered postnatal stem cell behavior and a failure in postnatal muscle growth. Dev. Biol. 2005, 281:171-183.
17. Relaix F., Wei X.J., Wu X., Sassoon D.A. Peg3/Pw1 is an imprinted gene involved in the TNF-NFkappaB signal transduction pathway. Nat. Genet. 1998, 18:287-291.
18. Schwarzkopf M., Coletti D., Sassoon D., Marazzi G. Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway. Genes Dev. 2006, 20:3440-3452.
19. Mitchell K.J., Pannerec A., Cadot B., Parlakian A., Besson V., Gomes E.R., Marazzi G., Sassoon D.A. Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development. Nat. Cell Biol. 2010, 12:257-266.
20. Muller B., Hedrich K., Kock N., Dragasevic N., Svetel M., Garrels J., Landt O., Nitschke M., Pramstaller P.P., Reik W., Schwinger E., Sperner J., Ozelius L., Kostic V., Klein C. Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am. J. Hum. Genet. 2002, 71:1303-1311.
21. Casola S., Pedone P.V., Cavazzana A.O., Basso G., Luksch R., d'Amore E.S., Carli M., Bruni C.B., Riccio A. Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma. Oncogene 1997, 14:1503-1510.
22. Zhan S., Shapiro D.N., Helman L.J. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J. Clin. Invest. 1994, 94:445-448.
23. Zhou H., Brockington M., Jungbluth H., Monk D., Stanier P., Sewry C.A., Moore G.E., Muntoni F. Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies. Am. J. Hum. Genet. 2006, 79:859-868.
24. Tsumagari K., Baribault C., Terragni J., Chandra S., Renshaw C., Sun Z., Song L., Crawford G.E., Pradhan S., Lacey M., Ehrlich M. DNA methylation and differentiation: HOX genes in muscle cells. Epigenetics Chromatin 2013, 6:25.
25. Tsumagari K., Baribault C., Terragni J., Varley K.E., Gertz J., Pradhan S., Badoo M., Crain C.M., Song L., Crawford G.E., Myers R.M., Lacey M., Ehrlich M. Early de novo DNA methylation and prolonged demethylation in the muscle lineage. Epigenetics 2013, 8:317-332.
26. Wu W., Ren Z., Liu H., Wang L., Huang R., Chen J., Zhang L., Li P., Xiong Y. Core promoter analysis of porcine Six1 gene and its regulation of the promoter activity by CpG methylation. Gene 2013, 529:238-244.
27. Terragni J., Zhang G., Sun Z., Pradhan S., Song L., Crawford G.E., Lacey M., Ehrlich M. Notch signaling genes: myogenic DNA hypomethylation and 5-hydroxymethylcytosine. Epigenetics 2014, 9:842-850.
28. Laker R.C., Lillard T.S., Okutsu M., Zhang M., Hoehn K.L., Connelly J.J., Yan Z. Exercise prevents maternal high-fat diet-induced hypermethylation of the Pgc-1alpha gene and age-dependent metabolic dysfunction in the offspring. Diabetes 2014, 63:1605-1611.
29. Barres R., Osler M.E., Yan J., Rune A., Fritz T., Caidahl K., Krook A., Zierath J.R. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab. 2009, 10:189-198.
30. Barres R., Yan J., Egan B., Treebak J.T., Rasmussen M., Fritz T., Caidahl K., Krook A., O'Gorman D.J., Zierath J.R. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 2012, 15:405-411.
31. Rowlands D.S., Page R.A., Sukala W.R., Giri M., Ghimbovschi S.D., Hayat I., Cheema B.S., Lys I., Leikis M., Sheard P.W., Wakefield S.J., Breier B., Hathout Y., Brown K., Marathi R., Orkunoglu-Suer F.E., Devaney J.M., Leiken B., Many G., Krebs J., Hopkins W.G., Hoffman E.P. Multi-omic integrated networks connect DNA methylation and miRNA with skeletal muscle plasticity to chronic exercise in Type 2 diabetic obesity. Physiol. Genomics 2014, 46:747-765.
32. Zykovich A., Hubbard A., Flynn J.M., Tarnopolsky M., Fraga M.F., Kerksick C., Ogborn D., MacNeil L., Mooney S.D., Melov S. Genome-wide DNA methylation changes with age in disease-free human skeletal muscle. Aging Cell 2014, 13:360-366.
33. Himeda C.L., Debarnot C., Homma S., Beermann M.L., Miller J.B., Jones P.L., Jones T.I. Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene. Mol. Cell. Biol. 2014, 34:1942-1955.
34. Wong M., Gertz B., Chestnut B.A., Martin L.J. Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS. Front. Cell. Neurosci. 2013, 7:279.
35. Mohn F., Weber M., Rebhan M., Roloff T.C., Richter J., Stadler M.B., Bibel M., Schubeler D. Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol. Cell 2008, 30:755-766.
36. Liu L., Cheung T.H., Charville G.W., Hurgo B.M., Leavitt T., Shih J., Brunet A., Rando T.A. Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging. Cell Rep. 2013, 4:189-204.
37. Juan A.H., Derfoul A., Feng X., Ryall J.G., Dell'Orso S., Pasut A., Zare H., Simone J.M., Rudnicki M.A., Sartorelli V. Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells. Genes Dev. 2011, 25:789-794.
38. Weake V.M., Workman J.L. Histone ubiquitination: triggering gene activity. Mol. Cell 2008, 29:653-663.
39. Henry K.W., Wyce A., Lo W.S., Duggan L.J., Emre N.C., Kao C.F., Pillus L., Shilatifard A., Osley M.A., Berger S.L. Transcriptional activation via sequential histone H2B ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8. Genes Dev. 2003, 17:2648-2663.
40. Bonizec M., Herissant L., Pokrzywa W., Geng F., Wenzel S., Howard G.C., Rodriguez P., Krause S., Tansey W.P., Hoppe T., Dargemont C. The ubiquitin-selective chaperone Cdc48/p97 associates with Ubx3 to modulate monoubiquitylation of histone H2B. Nucleic Acids Res. 2014, 42:10975-10986.
41. Langan T.A. Histone phosphorylation: stimulation by adenosine 3',5'-monophosphate. Science 1968, 162:579-580.
42. Langan T.A. Cyclic AMP and histone phosphorylation. Ann. N. Y. Acad. Sci. 1971, 185:166-180.
43. Shiio Y., Eisenman R.N. Histone sumoylation is associated with transcriptional repression. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:13225-13230.
44. Martinez-Zamudio R., Ha H.C. Histone ADP-ribosylation facilitates gene transcription by directly remodeling nucleosomes. Mol. Cell. Biol. 2012, 32:2490-2502.
45. Martinez-Zamudio R.I., Ha H.C. PARP1 enhances inflammatory cytokine expression by alteration of promoter chromatin structure in microglia. Brain Behav. 2014, 4:552-565.
46. Messner S., Hottiger M.O. Histone ADP-ribosylation in DNA repair, replication and transcription. Trends Cell Biol. 2011, 21:534-542.
47. Gyorgy B., Toth E., Tarcsa E., Falus A., Buzas E.I. Citrullination: a posttranslational modification in health and disease. Int. J. Biochem. Cell Biol. 2006, 38:1662-1677.
48. Turner B.M. Histone acetylation and an epigenetic code. Bioessays 2000, 22:836-845.
49. Haberland M., Montgomery R.L., Olson E.N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 2009, 10:32-42.
50. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 1998, 12:599-606.
51. Fischle W., Dequiedt F., Hendzel M.J., Guenther M.G., Lazar M.A., Voelter W., Verdin E. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 2002, 9:45-57.
52. Jones P., Altamura S., De F.R., Gallinari P., Lahm A., Neddermann P., Rowley M., Serafini S., Steinkuhler C. Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases. Bioorg. Med. Chem. Lett. 2008, 18:1814-1819.
53. Lahm A., Paolini C., Pallaoro M., Nardi M.C., Jones P., Neddermann P., Sambucini S., Bottomley M.J., Lo S.P., Carfi A., Koch U., De F.R., Steinkuhler C., Gallinari P. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17335-17340.
54. Mal A., Sturniolo M., Schiltz R.L., Ghosh M.K., Harter M.L. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. EMBO J. 2001, 20:1739-1753.
55. Puri P.L., Iezzi S., Stiegler P., Chen T.T., Schiltz R.L., Muscat G.E., Giordano A., Kedes L., Wang J.Y., Sartorelli V. Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol. Cell 2001, 8:885-897.
56. Puri P.L., Avantaggiati M.L., Balsano C., Sang N., Graessmann A., Giordano A., Levrero M. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 1997, 16:369-383.
57. Puri P.L., Sartorelli V., Yang X.J., Hamamori Y., Ogryzko V.V., Howard B.H., Kedes L., Wang J.Y., Graessmann A., Nakatani Y., Levrero M. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell 1997, 1:35-45.
58. Sartorelli V., Puri P.L., Hamamori Y., Ogryzko V., Chung G., Nakatani Y., Wang J.Y., Kedes L. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol. Cell 1999, 4:725-734.
59. Lu J., McKinsey T.A., Zhang C.L., Olson E.N. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 2000, 6:233-244.
60. Lagger G., O'Carroll D., Rembold M., Khier H., Tischler J., Weitzer G., Schuettengruber B., Hauser C., Brunmeir R., Jenuwein T., Seiser C. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 2002, 21:2672-2681.
61. Montgomery R.L., Davis C.A., Potthoff M.J., Haberland M., Fielitz J., Qi X., Hill J.A., Richardson J.A., Olson E.N. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev. 2007, 21:1790-1802.
62. Montgomery R.L., Potthoff M.J., Haberland M., Qi X., Matsuzaki S., Humphries K.M., Richardson J.A., Bassel-Duby R., Olson E.N. Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice. J. Clin. Invest. 2008, 118:3588-3597.
63. Vega R.B., Matsuda K., Oh J., Barbosa A.C., Yang X., Meadows E., McAnally J., Pomajzl C., Shelton J.M., Richardson J.A., Karsenty G., Olson E.N. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004, 119:555-566.
64. Moresi V., Carrer M., Grueter C.E., Rifki O.F., Shelton J.M., Richardson J.A., Bassel-Duby R., Olson E.N. Histone deacetylases 1 and 2 regulate autophagy flux and skeletal muscle homeostasis in mice. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:1649-1654.
65. Potthoff M.J., Wu H., Arnold M.A., Shelton J.M., Backs J., McAnally J., Richardson J.A., Bassel-Duby R., Olson E.N. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J. Clin. Investig. 2007, 117:2459-2467.
66. Moresi V., Williams A.H., Meadows E., Flynn J.M., Potthoff M.J., McAnally J., Shelton J.M., Backs J., Klein W.H., Richardson J.A., Bassel-Duby R., Olson E.N. Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 2010, 143:35-45.
67. Choi M.C., Cohen T.J., Barrientos T., Wang B., Li M., Simmons B.J., Yang J.S., Cox G.A., Zhao Y., Yao T.P. A direct HDAC4-MAP kinase crosstalk activates muscle atrophy program. Mol. Cell 2012, 47:122-132.
68. Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009, 326:1549-1554.
69. Bruneteau G., Simonet T., Bauche S., Mandjee N., Malfatti E., Girard E., Tanguy M.L., Behin A., Khiami F., Sariali E., Hell-Remy C., Salachas F., Pradat P.F., Fournier E., Lacomblez L., Koenig J., Romero N.B., Fontaine B., Meininger V., Schaeffer L., Hantai D. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain 2013, 136:2359-2368.
70. Avila A.M., Burnett B.G., Taye A.A., Gabanella F., Knight M.A., Hartenstein P., Cizman Z., Di Prospero N.A., Pellizzoni L., Fischbeck K.H., Sumner C.J. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J. Clin. Invest. 2007, 117:659-671.
71. Yoo Y.E., Ko C.P. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2011, 231:147-159.
72. Consalvi S., Mozzetta C., Bettica P., Germani M., Fiorentini F., Del B.F., Rocchetti M., Leoni F., Monzani V., Mascagni P., Puri P.L., Saccone V. Preclinical studies in the mdx mouse model of Duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat. Mol. Med. 2013, 19:79-87.
73. Harrison I.F., Dexter D.T. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?. Pharmacol. Ther. 2013, 140:34-52.
74. Bolden J.E., Peart M.J., Johnstone R.W. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 2006, 5:769-784.
75. El-Khoury V., Pierson S., Szwarcbart E., Brons N.H., Roland O., Cherrier-De W.S., Plawny L., Van D.E., Berchem G. Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia. Leukemia 2014, 28:1636-1646.
76. Xu W.S., Parmigiani R.B., Marks P.A. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 2007, 26:5541-5552.
77. Zhang Y., Ren J. Targeting autophagy for the therapeutic application of histone deacetylase inhibitors in ischemia/reperfusion heart injury. Circulation 2014, 129:1088-1091.
78. Minetti G.C., Colussi C., Adami R., Serra C., Mozzetta C., Parente V., Fortuni S., Straino S., Sampaolesi M., Di P.M., Illi B., Gallinari P., Steinkuhler C., Capogrossi M.C., Sartorelli V., Bottinelli R., Gaetano C., Puri P.L. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat. Med. 2006, 12:1147-1150.
79. Mozzetta C., Consalvi S., Saccone V., Tierney M., Diamantini A., Mitchell K.J., Marazzi G., Borsellino G., Battistini L., Sassoon D., Sacco A., Puri P.L. Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol. Med. 2013, 5:626-639.
80. Colussi C., Mozzetta C., Gurtner A., Illi B., Rosati J., Straino S., Ragone G., Pescatori M., Zaccagnini G., Antonini A., Minetti G., Martelli F., Piaggio G., Gallinari P., Steinkuhler C., Clementi E., Dell'Aversana C., Altucci L., Mai A., Capogrossi M.C., Puri P.L., Gaetano C. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:19183-19187.
81. Choi M.C., Ryu S., Hao R., Wang B., Kapur M., Fan C.M., Yao T.P. HDAC4 promotes Pax7-dependent satellite cell activation and muscle regeneration. EMBO Rep. 2014, 15:1175-1183.
82. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
83. Bernstein E., Kim S.Y., Carmell M.A., Murchison E.P., Alcorn H., Li M.Z., Mills A.A., Elledge S.J., Anderson K.V., Hannon G.J. Dicer is essential for mouse development. Nat. Genet. 2003, 35:215-217.
84. Cacchiarelli D., Legnini I., Martone J., Cazzella V., D'Amico A., Bertini E., Bozzoni I. miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol. Med. 2011, 3:258-265.
85. Danborg P.B., Simonsen A.H., Waldemar G., Heegaard N.H. The potential of microRNAs as biofluid markers of neurodegenerative diseases - a systematic review. Biomarkers 2014, 19:259-268.
86. Eisenberg I., Eran A., Nishino I., Moggio M., Lamperti C., Amato A.A., Lidov H.G., Kang P.B., North K.N., Mitrani-Rosenbaum S., Flanigan K.M., Neely L.A., Whitney D., Beggs A.H., Kohane I.S., Kunkel L.M. Distinctive patterns of microRNA expression in primary muscular disorders. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17016-17021.
87. Hrdlickova B., de Almeida R.C., Borek Z., Withoff S. Genetic variation in the non-coding genome: involvement of micro-RNAs and long non-coding RNAs in disease. Biochim. Biophys. Acta 2014, 1842:1910-1922.
88. Jarry J., Schadendorf D., Greenwood C., Spatz A., van Kempen L.C. The validity of circulating microRNAs in oncology: five years of challenges and contradictions. Mol. Oncol. 2014, 8:819-829.
89. O'Rourke J.R., Georges S.A., Seay H.R., Tapscott S.J., McManus M.T., Goldhamer D.J., Swanson M.S., Harfe B.D. Essential role for Dicer during skeletal muscle development. Dev. Biol. 2007, 311:359-368.
90. McCarthy J.J. MicroRNA-206: the skeletal muscle-specific myomiR. Biochim. Biophys. Acta 2008, 1779:682-691.
91. Small E.M., O'Rourke J.R., Moresi V., Sutherland L.B., McAnally J., Gerard R.D., Richardson J.A., Olson E.N. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4218-4223.
92. van R.E., Sutherland L.B., Qi X., Richardson J.A., Hill J., Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316:575-579.
93. van R.E., Quiat D., Johnson B.A., Sutherland L.B., Qi X., Richardson J.A., Kelm R.J., Olson E.N. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell 2009, 17:662-673.
94. Williams A.H., Liu N., van R.E., Olson E.N. MicroRNA control of muscle development and disease. Curr. Opin. Cell Biol. 2009, 21:461-469.
95. Lu L., Zhou L., Chen E.Z., Sun K., Jiang P., Wang L., Su X., Sun H., Wang H. A Novel YY1-miR-1 regulatory circuit in skeletal myogenesis revealed by genome-wide prediction of YY1-miRNA network. PLoS One 2012, 7:e27596.
96. Cheung T.H., Quach N.L., Charville G.W., Liu L., Park L., Edalati A., Yoo B., Hoang P., Rando T.A. Maintenance of muscle stem-cell quiescence by microRNA-489. Nature 2012, 482:524-528.
97. Crist C.G., Montarras D., Buckingham M. Muscle satellite cells are primed for myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by microRNA-31 in mRNP granules. Cell Stem Cell 2012, 11:118-126.
98. Crist C.G., Montarras D., Pallafacchina G., Rocancourt D., Cumano A., Conway S.J., Buckingham M. Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13383-13387.
99. McFarlane C., Vajjala A., Arigela H., Lokireddy S., Ge X., Bonala S., Manickam R., Kambadur R., Sharma M. Negative auto-regulation of myostatin expression is mediated by Smad3 and microRNA-27. PLoS One 2014, 9:e87687.
100. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., Conlon F.L., Wang D.Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006, 38:228-233.
101. Chen Y., Gelfond J., McManus L.M., Shireman P.K. Temporal microRNA expression during in vitro myogenic progenitor cell proliferation and differentiation: regulation of proliferation by miR-682. Physiol. Genomics 2011, 43:621-630.
102. Boutet S.C., Cheung T.H., Quach N.L., Liu L., Prescott S.L., Edalati A., Iori K., Rando T.A. Alternative polyadenylation mediates microRNA regulation of muscle stem cell function. Cell Stem Cell 2012, 10:327-336.
103. Goljanek-Whysall K., Pais H., Rathjen T., Sweetman D., Dalmay T., Munsterberg A. Regulation of multiple target genes by miR-1 and miR-206 is pivotal for C2C12 myoblast differentiation. J. Cell Sci. 2012, 125:3590-3600.
104. Liu H., Chen S.E., Jin B., Carson J.A., Niu A., Durham W., Lai J.Y., Li Y.P. TIMP3: a physiological regulator of adult myogenesis. J. Cell Sci. 2010, 123:2914-2921.
105. Liu N., Williams A.H., Maxeiner J.M., Bezprozvannaya S., Shelton J.M., Richardson J.A., Bassel-Duby R., Olson E.N. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J. Clin. Invest. 2012, 122:2054-2065.
106. Winbanks C.E., Wang B., Beyer C., Koh P., White L., Kantharidis P., Gregorevic P. TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J. Biol. Chem. 2011, 286:13805-13814.
107. Dey B.K., Gagan J., Yan Z., Dutta A. miR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes Dev. 2012, 26:2180-2191.
108. Chen J.F., Tao Y., Li J., Deng Z., Yan Z., Xiao X., Wang D.Z. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J. Cell Biol. 2010, 190:867-879.
109. Motohashi N., Alexander M.S., Shimizu-Motohashi Y., Myers J.A., Kawahara G., Kunkel L.M. Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis. J. Cell Sci. 2013, 126:2678-2691.
110. Jash S., Dhar G., Ghosh U., Adhya S. Role of the mTORC1 complex in satellite cell activation by RNA-induced mitochondrial restoration: dual control of cyclin D1 through microRNAs. Mol. Cell. Biol. 2014, 34:3594-3606.
111. Feng Y., Niu L.L., Wei W., Zhang W.Y., Li X.Y., Cao J.H., Zhao S.H. A feedback circuit between miR-133 and the ERK1/2 pathway involving an exquisite mechanism for regulating myoblast proliferation and differentiation. Cell Death Dis. 2013, 4:e934.
112. Juan A.H., Kumar R.M., Marx J.G., Young R.A., Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol. Cell 2009, 36:61-74.
113. Wong C.F., Tellam R.L. MicroRNA-26a targets the histone methyltransferase enhancer of Zeste homolog 2 during myogenesis. J. Biol. Chem. 2008, 283:9836-9843.
114. Wang H., Garzon R., Sun H., Ladner K.J., Singh R., Dahlman J., Cheng A., Hall B.M., Qualman S.J., Chandler D.S., Croce C.M., Guttridge D.C. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008, 14:369-381.
115. Huang M.B., Xu H., Xie S.J., Zhou H., Qu L.H. Insulin-like growth factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis. PLoS One 2011, 6:e29173.
116. Mishima Y., breu-Goodger C., Staton A.A., Stahlhut C., Shou C., Cheng C., Gerstein M., Enright A.J., Giraldez A.J. Zebrafish miR-1 and miR-133 shape muscle gene expression and regulate sarcomeric actin organization. Genes Dev. 2009, 23:619-632.
117. Yin H., Pasut A., Soleimani V.D., Bentzinger C.F., Antoun G., Thorn S., Seale P., Fernando P., van I.W., Grosveld F., Dekemp R.A., Boushel R., Harper M.E., Rudnicki M.A. MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16. Cell Metab. 2013, 17:210-224.
118. Wang L., Chen X., Zheng Y., Li F., Lu Z., Chen C., Liu J., Wang Y., Peng Y., Shen Z., Gao J., Zhu M., Chen H. MiR-23a inhibits myogenic differentiation through down regulation of fast myosin heavy chain isoforms. Exp. Cell Res. 2012, 318:2324-2334.
119. van R.E., Liu N., Olson E.N. MicroRNAs flex their muscles. Trends Genet. 2008, 24:159-166.
120. Liu N., Bezprozvannaya S., Shelton J.M., Frisard M.I., Hulver M.W., McMillan R.P., Wu Y., Voelker K.A., Grange R.W., Richardson J.A., Bassel-Duby R., Olson E.N. Mice lacking microRNA 133a develop dynamin 2-dependent centronuclear myopathy. J. Clin. Invest. 2011, 121:3258-3268.